References
- WHOThe Top 10 Causes of DeathGenevaWorld Health Organization2014
- LokkeALangePScharlingHFabriciusPVestboJDeveloping COPD: a 25 year follow up study of the general populationThorax2006611193593917071833
- LundbackBLindbergALindstromMNot 15 but 50% of smokers develop COPD? – Report from the obstructive lung disease in northern Sweden studiesRespir Med200397211512212587960
- TaylorJDCOPD and the response of the lung to tobacco smoke exposurePulm Pharmacol Ther201023537638320382250
- NuortiJPButlerJCFarleyMMCigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance TeamN Engl J Med20003421068168910706897
- VossMWonnenbergBHoneckerACigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in miceRespir Res20151614125890119
- SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med2008359222355236519038881
- CabelloHTorresACelisRBacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic studyEur Respir J1997105113711449163659
- BeasleyVJoshiPVSinganayagamAMolyneauxPLJohnstonSLMalliaPLung microbiology and exacerbations in COPDInt J Chron Obstruct Pulmon Dis2012755556922969296
- GriggJThe platelet activating factor receptor: a new anti-infective target in respiratory disease?Thorax201267984084122802333
- ShuklaSSohalSReidDGriggJWaltersEPlatelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroidsPaper presented at: European Respiratory Society Annual Congress2013Barcelona, Spain
- ShuklaSDPlatelet-activating factor receptor and signal transduction mechanismsFASEB J199266229623011312046
- CundellDRGerardNPGerardCIdanpaan-HeikkilaITuomanenEIStreptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factorNature199537765484354387566121
- SwordsWEBuscherBAVer Steeg IiKNon-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptorMol Microbiol2000371132710931302
- ShuklaSDSohalSSO’TooleRFEapenMSWaltersEHPlatelet activating factor receptor: gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic targetExpert Rev Respir Med20159447348526207607
- ShuklaSDSohalSSMahmoodMQReidDMullerHKWaltersEHAirway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2014985386125143722
- ShuklaSDMullerHKLathamRSohalSSWaltersEHPlatelet-activating factor receptor (PAFr) is upregulated in small airways and alveoli of smokers and COPD patientsRespirology201621350451026662379
- GriggJWaltersHSohalSSCigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cellsThorax2012671090891322550083
- CellaiCLaurenzanaAVannucchiAMGrowth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086Br J Cancer200694111637164216721373
- CellaiCLaurenzanaAVannucchiAMDella MalvaNBianchiLPaolettiFSpecific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cellsFASEB J200216773373511923217
- KatoMImotoKMiyakeHOdaTMiyajiSNakamuraMApafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigsJ Pharmacol Sci200495443544215286429
- AvadhanulaVRodriguezCAUlettGCBakaletzLOAddersonEENontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expressionInfect Immun200674283083816428725
- AdamouJEWizemannTMBarrenPLangermannSAdherence of Streptococcus pneumoniae to Human Bronchial Epithelial Cells (BEAS-2B)Infection Immun1998662820822
- MushtaqNEzzatiMHallLAdhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matterJ Allergy Clin Immunol2011127512361242.e123221247619
- LathamRZhangBTristramSIdentifying Haemophilus haemolyticus and Haemophilus influenzae by SYBR Green real-time PCRJ Microbiol Methods2015112676925753676
- SaliABlundellTLComparative protein modelling by satisfaction of spatial restraintsJ Mol Biol199323437798158254673
- ZhangJYangJJangRZhangYGPCR-I-TASSER: A hybrid approach to G protein-coupled receptor structure modeling and the application to the human genomeStructure20152381538154926190572
- TrottOOlsonAJAutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJ Comput Chem201031245546119499576
- O’BoyleNMBanckMJamesCAMorleyCVandermeerschTHutchisonGROpen Babel: an open chemical toolboxJ Cheminform201133321982300
- SannerMFPython: a programming language for software integration and developmentJ Mol Graph Model1999171576110660911
- Marti-LliterasPLopez-GomezAMauroSNontypable Haemophilus influenzae displays a prevalent surface structure molecular pattern in clinical isolatesPLoS One201166e2113321698169
- SwordsWEKettererMRShaoJCampbellCAWeiserJNApicellaMABinding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signallingCell Microbiol20013852553611488814
- ClarkSESnowJLiJZolaTAWeiserJNPhosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzaePLoS Pathog201283e100252122396641
- WeiserJNPanNMcGowanKLMusherDMartinARichardsJPhosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive proteinJ Exp Med199818746316409463413
- WeiserJNShchepetovMChongSTDecoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzaeInfect Immun19976539439509038301
- McCreaKWXieJMarrsCFGilsdorfJRPrevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticusBMC Microbiol20101028621073698
- WeiserJNLoveJMMoxonERThe molecular mechanism of phase variation of H. influenzae lipopolysaccharideCell19895946576652479481
- MichelVYuanZRamsubirSBakovicMCholine transport for phospholipid synthesisExp Biol Med (Maywood)2006231549050416636297
- FanXPericoneCDLysenkoEGoldfineHWeiserJNMultiple mechanisms for choline transport and utilization in Haemophilus influenzaeMol Microbiol200350253754814617177
- RijneveldAWWeijerSFlorquinSImproved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient miceJ Infect Dis2004189471171614767826
- van der SluijsKFvan EldenLJNijhuisMInvolvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumoniaAm J Physiol Lung Cell Mol Physiol20062901L194L19916100290
- IshizukaSYamayaMSuzukiTAcid exposure stimulates the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells: effects on platelet-activating factor receptor expressionAm J Respir Cell Mol Biol200124445946811306440